C4 Therapeutics (NASDAQ:CCCC) Insider Buying and Selling Activity
21.04% of C4 Therapeutics' shares are owned by company executives, directors and other insiders. Over the past twelve months, insiders at the have sold shares 15 time(s), totalling $7,496,932.52. During the same time, C4 Therapeutics insiders have purchased shares 2 time(s), totalling $195,567.00. Insiders that have bought shares include Marc A Cohen, and William Mckee. Insiders that have sold shares include Elena Prokupets, Malcolm Salter, Stewart Fisher, Jolie Siegel, and Adam Crystal.
Insider Buying and Selling by Quarter
C4 Therapeutics (NASDAQ CCCC) Insider Trading History
(Data available from 1/1/2013 forward)
C4 Therapeutics (NASDAQ:CCCC) Insider Trade Frequently Asked Questions
Who is on C4 Therapeutics's Insider Roster?
What percentage of C4 Therapeutics stock is owned by insiders?
Which C4 Therapeutics insiders have been buying company stock?
The following insiders have purchased C4 Therapeutics stock in the last 24 months: Marc A Cohen ($95,570.00), and William Mckee ($99,997.00).
How much insider buying is happening at C4 Therapeutics?
Insiders have purchased a total of 10,293 C4 Therapeutics shares in the last 24 months for a total of $195,567.00 bought.
Which C4 Therapeutics insiders have been selling company stock?
The following insiders have sold C4 Therapeutics stock in the last 24 months: Adam Crystal ($1,136,250.00), Elena Prokupets ($4,868,432.97), Jolie Siegel ($562,500.00), Malcolm Salter ($115,069.55), and Stewart Fisher ($814,680.00).
How much insider selling is happening at C4 Therapeutics?
Insiders have sold a total of 163,781 C4 Therapeutics shares in the last 24 months for a total of $7,496,932.52 sold.
